Uncommon Cures® Information
Contact top employees from
Uncommon Cures®
Summary
Uncommon Cures® was launched in 2023 with the mission to streamline orphan drug clinical development, which is unnecessarily slow, expensive, and likely to fail due to non-drug factors. Led by an expe...Show more
Industries
Research
Headquarters Location
Employees Size
10-50 employees
Specialties
rare disease, genetics, clinical trials, inborn errors of metabolism, gene therapy
Founded
2023
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Length of Employment
Employee tenure at Uncommon Cures® shows a diverse range of experience levels:
25% have been with the company for less than 1 year75% for 1–2 yearsEx-employees positions
In Company
In New Company
Contact top employees from
Uncommon Cures®
Marshall Summar
Chief Executive Officer
Rob Freishtat
President | Co-founder | Board Member
Alan Freeman
Chief Strategy Officer, General Counsel & Corporate Secretary
Keith Authelet
Chief Operating Officer (Acting)
Rachael Batabyal
Principal Investigator, USA
Penny Toren
Chief Regulatory and Quality Officer
Chuck Bucklar
Chief Business Officer
Joshua Crago
VP of Pharmacy Operations
Tom Moreno
Chief Innovation Officer (CIO)
Alaba Obaro
Senior CRA II
Kerri Gallagher
Vice President of Clinical Operations
Wendy Sclafani
Vice President of Clinical Operations
Tamanna Roshan Lal MB ChB
Chief Medical Officer
Christiana Bakare
Director of Business Operations and Human Resources at Uncommon Cures LLC (Founding Executive)
Keerthi Akula
Intern
Marshall Summar
Chief Executive Officer
